Skip to main
TEVA

Teva Pharmaceutical (TEVA) Market Capitalization Overview

Market Cap: $37.16B as of Jan 7, 2026

$37.16B
$4.52B (13.84%)past month
As of Jan 7, 2026, Teva Pharmaceutical (TEVA) has a market capitalization of $37.16B. Over the past 30 days, its market cap has increased by 15.83%, while in the last 12 months, it has increased by 3.81%.

Market capitalization represents the total value of Teva Pharmaceutical as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Teva Pharmaceutical (TEVA) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Teva Pharmaceutical (TEVA) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Teva Pharmaceutical (TEVA) Market Cap History

DateMarket CapChange
Dec 1, 2025$30.65B+30.21%
Nov 3, 2025$23.54B+2.29%
Oct 1, 2025$23.01B+6.99%
Sep 2, 2025$21.51B+21.91%
Aug 1, 2025$17.64B-7.57%
Jul 1, 2025$19.09B-3.51%
Jun 2, 2025$19.78B+10.50%
May 1, 2025$17.90B+2.16%
Apr 1, 2025$17.52B-4.44%
Mar 3, 2025$18.34B-6.87%
Feb 3, 2025$19.69B-18.54%
Jan 2, 2025$24.17B+28.11%

Teva Pharmaceutical (TEVA) End of Year Market Cap History

DateMarket CapChange
2026$37.16B+3.81%
2025$35.80B+43.14%
2024$25.01B+113.70%
2023$11.71B+15.54%
2022$10.13B+14.64%
2021$8.84B

FAQs About Teva Pharmaceutical (TEVA) Market Cap

As of Jan 7, 2026, the market capitalization of Teva Pharmaceutical (TEVA) is $37.16B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Teva Pharmaceutical’s market capitalization has increased by 13.84%, changing from $32.64B to $37.16B as of Jan 7, 2026.

In the last 3 months, Teva Pharmaceutical’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Teva Pharmaceutical’s market capitalization increased from $25.01B in January to $35.80B in December, reflecting a 43.14% change.

In the past five years, Teva Pharmaceutical (TEVA) has had a compound annual growth rate (CAGR) of 32.29% in market capitalization. This means its market cap has grown at an average rate of 32.29% per year.

Teva Pharmaceutical (TEVA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.